EP Patent
EP0266896B1 — 7-( (meta-substituted) phenylglycine) 1-carba-1-dethiacephalosporins
Assigned to Eli Lilly and Co · Expires 1992-08-05 · 34y expired
What this patent protects
Compounds of the Formula I <CHEM> wherein R1 is C1 to C4 alkyl, and their pharmaceutically-acceptable salts are valuable antibiotics.
USPTO Abstract
Compounds of the Formula I <CHEM> wherein R1 is C1 to C4 alkyl, and their pharmaceutically-acceptable salts are valuable antibiotics.
Drugs covered by this patent
- Zetia (EZETIMIBE) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.